← Exoskeletons

Hypershell

ExoskeletonExoskeletonActive
Total funding
$120M across the Series B series (incl. $50M Series B+, May 2026)
Valuation
~$400M post-money
Founded
2021
Headquarters
Shanghai / Shenzhen, China
Segment
Powered – Lower Body (hip assist)
Status
Private
Target market
Consumer (outdoor/hiking), Industrial
Founders
Kelvin Sun (CEO & Founder)

Latest research

Updated Sep 8, 2026

Hypershell raised a $50M Series B+ in May 2026 co-led by Ant Group and Meituan Dragonball Capital, taking its Series B series to $120M at a post-money valuation near $400M. It is the clearest example of consumer-grade exoskeletons attracting large growth capital.

  • $50M Series B+ (May 2026) co-led by Ant Group and Meituan Dragonball Capital
  • Sofina and Granite Asia joined the round
  • Series B series totals $120M; ~$400M post-money valuation
  • Earlier pre-B and Series B rounds totalled ~$70M

Notes

Raised $120M+ Series B. World's top-selling consumer exoskeleton brand. Team ~100 people.

Backed by

Click an investor to see everything else they back.